- Home
- DMC vs SVRA Comparison
DMC vs SVRA Comparison
Compare DMC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$5.46
Company Overview
Basic Information| Metric | DMC | SVRA |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | DMC | SVRA |
|---|---|---|
| Price | $29.80 | $5.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 356.7K | ★ 1.8M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $430.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.51 | $2.43 |
| 52 Week High | $30.49 | $7.01 |
Technical Indicators
Market Signals| Indicator | DMC | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 62.30 | N/A |
| Support Level | $28.00 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.77 | 0.00 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 72.79 | 0.00 |
Price Performance
Historical Comparison DMC
SVRA
About SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).